KEY TAKEAWAY:
-Pharma CEO’s should not be evaluated on the company’s stock price alone.
-When Wall Street wins patients usually lose.
-Mr Merck was right, putting patients first will lead to profits.
Pharma CEO’s
KEY TAKEAWAY: Some pharma company CEO’s are living in a bubble and don’t understand why consumers are angry at the pharma industry. Despite the fact that some cancer patients, for example, are living longer US consumers are sick of paying more for healthcare and prescription drugs.
KEY SUMMARY: Fobres, in a recent editorial, said “Pharma Needs A Leader In 2016” and I couldn’t agree more, but let’s be honest here, most pharma CEO’s are NOT leaders but rather high paid executives who bow to investor needs and demands.
KEY TAKEAWAY: When shareholders are prioritized patients usually find themselves on the short end of the stick. Can the two ever live together?